307 related articles for article (PubMed ID: 8172913)
1. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
[TBL] [Abstract][Full Text] [Related]
2. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
[TBL] [Abstract][Full Text] [Related]
3. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
Kramer W; Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
[TBL] [Abstract][Full Text] [Related]
5. Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide.
Kramer W; Oekonomopulos R; Pünter J; Summ HD
FEBS Lett; 1988 Mar; 229(2):355-9. PubMed ID: 2831099
[TBL] [Abstract][Full Text] [Related]
6. Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue.
Schwanstecher M; Löser S; Chudziak F; Bachmann C; Panten U
J Neurochem; 1994 Aug; 63(2):698-708. PubMed ID: 8035194
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial sulfonylurea receptor: identification and characterization.
Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a 65 kDa sulfonylurea receptor in rat pancreatic zymogen granule membranes.
Braun M; Anderie I; Thévenod F
FEBS Lett; 1997 Jul; 411(2-3):255-9. PubMed ID: 9271216
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein inhibition by glibenclamide and related compounds.
Golstein PE; Boom A; van Geffel J; Jacobs P; Masereel B; Beauwens R
Pflugers Arch; 1999 Apr; 437(5):652-60. PubMed ID: 10087141
[TBL] [Abstract][Full Text] [Related]
10. Characterization and solubilization of the sulphonylurea receptor in rat brain.
Niki I; Ashcroft SJ
Neuropharmacology; 1993 Oct; 32(10):951-7. PubMed ID: 8295717
[TBL] [Abstract][Full Text] [Related]
11. Characterization of sulfonylurea receptors in isolated human pancreatic islets.
Giannaccini G; Lupi R; Trincavelli ML; Navalesi R; Betti L; Marchetti P; Lucacchini A; Del Guerra S; Martini C
J Cell Biochem; 1998 Nov; 71(2):182-8. PubMed ID: 9779817
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the sulfonylurea receptor on beta cell membranes.
Gaines KL; Hamilton S; Boyd AE
J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
[TBL] [Abstract][Full Text] [Related]
15. Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog.
Aguilar-Bryan L; Nelson DA; Vu QA; Humphrey MB; Boyd AE
J Biol Chem; 1990 May; 265(14):8218-24. PubMed ID: 2110566
[TBL] [Abstract][Full Text] [Related]
16. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
Löffler C; Quast U
Br J Pharmacol; 1997 Feb; 120(3):476-80. PubMed ID: 9031752
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
Stephan D; Winkler M; Kühner P; Russ U; Quast U
Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
[TBL] [Abstract][Full Text] [Related]
19. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
Ueda K; Komine J; Matsuo M; Seino S; Amachi T
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
